Julia Cartwright explores how GLP-1 drugs protect kidneys through multiple pathways—reducing inflammation, scarring, and protein leakage while improving blood sugar and blood pressure. Research shows these medications lower kidney failure risk by 16% in diabetic and non-diabetic patients, offering hope beyond traditional treatments as a promising fourth pillar of kidney disease prevention.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI
Show More
Show Less